Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis-Reference-Cited by-同舟云学术

Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis

Published:2014-11-12 Issue:10 Volume:136 Page:2369-2377
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Benson Victoria S.¹,Kirichek Oksana¹,Beral Valerie,Green Jane¹

Affiliation:

1. Cancer Epidemiology Unit; Nuffield Department of Population Health; University of Oxford, Richard Doll Building; Roosevelt Drive Oxford OX3 7LF United Kingdom

Funder

Cancer Research UK

Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. 2007

2. Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis;Green;Int J Cancer,2011

3. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cogort study;Michaud;Cancer Epidemiol Biomarkers Prev,2010

4. Hormone replacement therapy and incidence of central nervous system tumours in the million women study;Benson;Int J Cancer,2010

5. Sex steroid hormone exposures and risk for meningioma;Jhawar;J Neurosurg,2003

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study;The Lancet Regional Health - Europe;2024-07

2. Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records;British Journal of Cancer;2024-06-24

3. Bridging the gap: exploring the causal relationship between metformin and tumors;Frontiers in Genetics;2024-06-19

4. Investigating the Relationship between Telomere-Related Gene Variants and Leukocyte Telomere Length in Optic Neuritis Patients;Journal of Clinical Medicine;2024-05-03

5. Use of progestogens and the risk of intracranial meningioma: national case-control study;BMJ;2024-03-27